{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:17:12Z","timestamp":1772209032765,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,28]]},"DOI":"10.7759\/cureus.61251","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T17:59:54Z","timestamp":1716919194000},"source":"Crossref","is-referenced-by-count":2,"title":["Anti-Ha Antisynthetase Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Vanessa P","family":"De Andrade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Miossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando H","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel K","family":"Shinjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo G","year":"2022","unstructured":"Zanframundo G, Faghihi-Kashani S, Scir\u00e8 CA, et al.. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022, 40:309-19. 10.55563\/clinexprheumatol\/8xj0b9","journal-title":"Clin Exp Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150514094935","article-title":"Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management","volume":"22","author":"Mirrakhimov AE","year":"2015","unstructured":"Mirrakhimov AE. Antisynthetase syndrome: a review of etiopathogenesis, diagnosis and management. Curr Med Chem. 2015, 22:1963 - 75. 10.2174\/0929867322666150514094935","journal-title":"Curr Med Chem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors GR","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?. Chest. 2010, 138:1464-74. 10.1378\/chest.10-0180","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega JC","year":"2014","unstructured":"Lega JC, Fabien N, Reynaud Q, et al.. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev. 2014, 13:883-91. 10.1016\/j.autrev.2014.03.004","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2397198320902667","article-title":"Antisynthetase syndrome: A distinct disease spectrum","volume":"5","author":"Huang K","year":"2020","unstructured":"Huang K, Aggarwal R. Antisynthetase syndrome: A distinct disease spectrum. J Scleroderma Relat Disord. 2020, 5:178-91. 10.1177\/2397198320902667","journal-title":"J Scleroderma Relat Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866087","article-title":"Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond","volume":"13","author":"Galindo-Feria AS","year":"2022","unstructured":"Galindo-Feria AS, Notarnicola A, Lundberg IE, Horuluoglu B. Aminoacyl-tRNA synthetases: on anti-synthetase syndrome and beyond. Front Immunol. 2022, 13:866087. 10.3389\/fimmu.2022.866087","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.10340","article-title":"Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)","volume":"22","author":"Yamano Y","year":"2023","unstructured":"Yamano Y, Muro Y, Takei R, et al.. Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies). Autoimmun Rev. 2023, 22:103403-10. 10.1016\/j.autrev.2023.10340","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(07)04","article-title":"Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis","volume":"68","author":"Cruellas MG","year":"2013","unstructured":"Cruellas MG, Viana Vdos S, Levy-Neto M, Souza FH, Shinjo SK. Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis. Clinics (Sao Paulo). 2013, 68:909-14. 10.6061\/clinics\/2013(07)04","journal-title":"Clinics (Sao Paulo)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75036-2","article-title":"An ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease","volume":"10","author":"Jayaraman V","year":"2020","unstructured":"Jayaraman V, Krishna K, Yang Y, et al.. An ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease. Sci Rep. 2020, 10:18085. 10.1038\/s41598-020-75036-2","journal-title":"Sci Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.09.020","article-title":"Antisynthetase syndrome - much more than just a myopathy","volume":"51","author":"Opinc AH","year":"2021","unstructured":"Opinc AH, Makowska JS. Antisynthetase syndrome - much more than just a myopathy. Semin Arthritis Rheum. 2021, 51:72-83. 10.1016\/j.semarthrit.2020.09.020","journal-title":"Semin Arthritis Rheum"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker JB","year":"2018","unstructured":"Lilleker JB, Vencovsky J, Wang G, et al.. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis. 2018, 77:30-9. 10.1136\/annrheumdis2017-211868","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092944","article-title":"Prevalence of novel myositis autoantibodies in a large cohort of patients with interstitial lung disease","volume":"9","author":"Moll SA","year":"2020","unstructured":"Moll SA, Platenburg MG, Platteel AC, et al.. Prevalence of novel myositis autoantibodies in a large cohort of patients with interstitial lung disease. J Clin Med. 2020, 9:10.3390\/jcm9092944","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/258990-anti-ha-antisynthetase-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T17:59:57Z","timestamp":1716919197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/258990-anti-ha-antisynthetase-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.61251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,28]]}}}